Atlas Trials

Endometrial Mucinous Adenocarcinoma

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Endometrial Mucinous Adenocarcinoma

RecordFirmDate
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma (NCT05112601)National Cancer Institute (NCI)2022-06-02
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers (NCT05049538)M.D. Anderson Cancer Center2019-06-18
Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers (NCT02020707)Mayo Clinic2014-02-24
Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer (NCT01642082)Gynecologic Oncology Group2012-09-01
Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer (NCT01225887)Gynecologic Oncology Group2011-10-01
Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer (NCT01440998)National Cancer Institute (NCI)2011-09-20
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer (NCT00492778)GOG Foundation2008-02-25

Track Endometrial Mucinous Adenocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.